Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 78.35
+0.11 (0.14%)
Apr 3, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Revenue
In the year 2024, Xiamen Amoytop Biotech had annual revenue of 2.82B CNY with 34.13% growth. Xiamen Amoytop Biotech had revenue of 862.46M in the quarter ending December 31, 2024, with 34.65% growth.
Revenue
2.82B
Revenue Growth
+34.13%
P/S Ratio
11.34
Revenue / Employee
1.44M
Employees
1,960
Market Cap
31.87B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Sichuan Biokin Pharmaceutical | 5.82B |